NALP3 Polyclonal Antibody

$THP-1 (H) cells were treated with or without LPS (10 \u00b5g\/ml) for 8 h, 25 \u03bcg total protein per lane of cell lysates (see on figure) probed with NALP3 polyclonal antibody, unconjugated (bs-25914R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.$

THP-1 (H) cells were treated with or without LPS (10 \u00b5g\/ml) for 8 h, 25 \u03bcg total protein per lane of cell lysates (see on figure) probed with NALP3 polyclonal antibody, unconjugated (bs-25914R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.

Applications

Reactivity

Human

Overview
Catalog #	bs-25914r-100ul
Product Name	NALP3 Polyclonal Antibody
Applications	WB
Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human NALP3
Clonality	Polyclonal
Isotype	IgG
Concentration	1mg/ml
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	114548
Swiss Prot	Q96P20
Subcellular location	Cytoplasm
Synonyms	AGTAVPRL; AII; AVP; C1orf7; CIAS1; CLR1.1; DFNA34; FCAS; FCAS1; FCU; KEFH; MWS; NALP3; PYPAF1; AII/AVP; Mmig1; NLRP3_HUMAN; NLRP3; Angiotensin/vasopressin receptor AII/AVP-like; Caterpiller protein 1.1 (CLR1.1); Cold-induced autoinflammatory syndrome 1 pr
Application Dilution
WB	=1:500-2000